These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3005907)

  • 1. Hydrodynamic parameters of opioid receptors from frog brain.
    Simon J; Benyhe S; Borsodi A; Wollemann M
    Neuropeptides; 1986 Jan; 7(1):23-6. PubMed ID: 3005907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of kappa-opioid receptor subtype from frog brain.
    Simon J; Benyhe S; Borsodi A; Szücs M; Wollemann M
    FEBS Lett; 1985 Apr; 183(2):395-7. PubMed ID: 2985433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics and physical parameters of rat brain opioid receptors solubilized by digitonin and CHAPS.
    Simon J; Benyhe S; Abutidze K; Borsodi A; Szücs M; Tóth G; Wollemann M
    J Neurochem; 1986 Mar; 46(3):695-701. PubMed ID: 3005492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilization and characterization of opioid binding sites from frog (Rana esculenta) brain.
    Simon J; Szücs M; Benyhe S; Borsodi A; Zeman P; Wollemann M
    J Neurochem; 1984 Oct; 43(4):957-63. PubMed ID: 6088699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of a kappa-opioid receptor subtype from frog brain.
    Simon J; Benyhe S; Hepp J; Khan A; Borsodi A; Szücs M; Medzihradszky K; Wollemann M
    Neuropeptides; 1987 Jul; 10(1):19-28. PubMed ID: 2890119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of kappa-opioid receptor subtype to apparent homogeneity from frog brain.
    Borsodi A; Khan A; Simon J; Benyhe S; Hepp J; Wollemann M; Medzihradszky K
    NIDA Res Monogr; 1986; 75():1-4. PubMed ID: 2828951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubilization and characterization of mu, delta, and kappa opioid binding sites from guinea pig brain: physical separation of kappa receptors.
    Itzhak Y; Hiller JM; Simon EJ
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4217-21. PubMed ID: 6330751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opiate receptor(s) of the frog brain: soluble-phase separation of the macromolecular complexes of an agonist and an antagonist].
    Puget A; Meunier JC
    C R Seances Acad Sci III; 1983; 296(10):475-8. PubMed ID: 6307492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and partial purification of solubilized active opiate receptors from toad brain.
    Ruegg UT; Cuenod S; Hiller JM; Gioannini T; Howells RD; Simon EJ
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4635-8. PubMed ID: 6270689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubilization of high-affinity [3H]tryptamine-binding sites from rat brain.
    Brüning G; Rommelspacher H
    Eur J Biochem; 1985 Nov; 153(1):95-9. PubMed ID: 4065152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilization and hydrodynamic characterization of the dihydropyridine receptor from rat ventricular muscle.
    Horne WA; Weiland GA; Oswald RE
    J Biol Chem; 1986 Mar; 261(8):3588-94. PubMed ID: 3005292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization, solubilization and purification of an opioid receptor from the brain of the frog Rana ridibunda.
    Pascaud A; Mollereau C; Puget A; Baillat G; Mazarguil H; Meunier JC
    NIDA Res Monogr; 1986; 75():5-8. PubMed ID: 2828997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilization and characterization of the kappa-opioid receptor type from guinea-pig cerebellum.
    Francés B; Moisand C; Meunier JC
    Eur J Pharmacol; 1988 May; 150(1-2):103-11. PubMed ID: 2841140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization of adrenal medullary opioid receptors.
    Kamikubo K; Murase H; Murayama M; Miura K
    Endocrinol Jpn; 1987 Dec; 34(6):897-901. PubMed ID: 2836184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid receptor labeling with the chloromethyl ketone derivative of [3H]Tyr-D-Ala-Gly-(Me)Phe-Gly-ol (DAMGO) II: Covalent labeling of mu opioid binding site by 3H-Tyr-D-Ala-Gly-(Me)Phe chloromethyl ketone.
    Oktem HA; Moitra J; Benyhe S; Toth G; Lajtha A; Borsodi A
    Life Sci; 1991; 48(18):1763-8. PubMed ID: 1850495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of solubilized muscarinic cholinergic receptors: binding and hydrodynamic properties.
    Baron B; Gavish M; Sokolovsky M
    Arch Biochem Biophys; 1985 Jul; 240(1):281-96. PubMed ID: 4015105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent precoupling of kappa- but not mu-opioid receptors with a G protein in the absence of agonist.
    Frances B; Puget A; Moisand C; Meunier JC
    Eur J Pharmacol; 1990 Jul; 189(1):1-9. PubMed ID: 2171960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilization and characterization of active opiate binding sites from mammalian brain.
    Howells RD; Gioannini TL; Hiller JM; Simon EJ
    J Pharmacol Exp Ther; 1982 Sep; 222(3):629-34. PubMed ID: 6286927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method for isolation of kappa-opioid binding sites by dynorphin affinity chromatography.
    Simon J; Benyhe S; Hepp J; Varga E; Medzihradszky K; Borsodi A; Wollemann M
    J Neurosci Res; 1990 Apr; 25(4):549-55. PubMed ID: 1972199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of agonist conformation and antagonist conformation in multiple opioid receptors.
    Ogawa N; Yamawaki Y; Kuroda H; Nukina I; Ofuji T
    Neurosci Lett; 1981 Dec; 27(2):205-9. PubMed ID: 6275320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.